 KEPPRA
|
GlaxoSmithKline Biopharma
|
| levetiracetam |
Antiepiléptico |
| 1000 mg comp.x 30 | $197.934,25 | (30/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $96.741,04 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $47.995,01 AF $149.939,24 |
|
|
|
|
| 1000 mg comp.x 60 | $271.901,23 | (30/01/26) |
| Importado |
| PAMI |
|
| AF $107.950,30 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $76.507,27 AF $195.393,96 |
|
|
|
|
| 500 mg comp.x 20 | $83.535,62 | (30/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $37.232,43 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $29.990,26 AF $53.545,36 |
|
|
|
|
| 500 mg comp.x 30 | $96.084,82 | (30/01/26) |
| Importado |
| PAMI |
|
| AF $38.810,71 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $47.995,01 AF $48.089,81 |
|
|
|
|
| 500 mg comp.x 60 | $185.553,53 | (30/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $90.689,91 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $76.507,27 AF $109.046,26 |
|
|
|
|
| sol.oral x 300 ml | $252.631,88 | (30/01/26) |
| Importado |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $106.894,86 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $92.837,80 AF $159.794,08 |
|
|
|
|
| |
